中国医学创新Issue(1)：103-104,2.DOI:10.3969/j.issn.1674-4985.2013.01.062
美兰在72例乳腺癌前哨淋巴结活检术中的临床应用分析
Clinical Value of Methylene Blue in Sentinel Lymph Node Biopsy for Breast Cancer:Report of 72 Cases
钟慕仪 1叶艳娜 2吴丽华 1张蓉 1张爱玲1
作者信息
- 1. 广东省东莞市人民医院 广东 东莞 523000
- 2. 东莞市卫生学校
- 折叠
摘要
Abstract
Objective:To evaluate the efficacy of sentinel lymph node biopsy(SLNB)by using methylene blue in the management of breast cancer. Method:From 2007-2012,totally 72 patients with breast cancer in our hospital,physical examination of no palpable lymph nodes,received subareolar or under the skin injection of methylene blue for SLNB,and then axillary lymph node dissection.Result:The SLNB was completed successfully in 70 of the patients(97.2%),in the 70 cases who received SLNB,SLN metastasis was found in 31 cases,;and not found in 39 cases.Conclusion:The metastasis to the axillary lymph nodes can be found earlier by sentinel lymph node biopsy.关键词
美兰/乳腺癌/前哨淋巴结Key words
Methylene blue/Breast cancer/Sentinel lymph node引用本文复制引用
钟慕仪,叶艳娜,吴丽华,张蓉,张爱玲..美兰在72例乳腺癌前哨淋巴结活检术中的临床应用分析[J].中国医学创新,2013,(1):103-104,2.
